Post Marketing Surveillance (PMS) Study to Assess Safety and Efficacy of Micardis in Patients With Essential Hypertension

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The objective of this PMS study was to monitor and assess the safety of Micardis tablets in patients with hypertension over a period of 6 years

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Boehringer Ingelheim
• Treatments: Telmisartan

Criteria

Inclusion Criteria:

• Male and female patients diagnosed with essential hypertension

• Patients without prior experience with Micardis tablet

Exclusion Criteria:

• Known hypersensitivity to Micardis tablet

• Pregnancy or breastfeeding

• Biliary atresia

• Severe hepatic failure patients

• Severe renal failure patients